» Articles » PMID: 25537861

Structural Features of β2 Adrenergic Receptor: Crystal Structures and Beyond

Overview
Journal Mol Cells
Publisher Elsevier
Date 2014 Dec 25
PMID 25537861
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The beta2-adrenergic receptor (β2AR) family, which is the largest family of cell surface receptors in humans. Extra attention has been focused on the human GPCRs because they have been studied as important protein targets for pharmaceutical drug development. In fact, approximately 40% of marketed drugs directly work on GPCRs. GPCRs respond to various extracellular stimuli, such as sensory signals, neurotransmitters, chemokines, and hormones, to induce structural changes at the cytoplasmic surface, activating downstream signaling pathways, primarily through interactions with heterotrimeric G proteins or through G-protein independent pathways, such as arrestin. Most GPCRs, except for rhodhopsin, which contains covalently linked 11 cis-retinal, bind to diffusible ligands, having various conformational states between inactive and active structures. The first human GPCR structure was determined using an inverse agonist bound β2AR in 2007 and since then, more than 20 distinct GPCR structures have been solved. However, most GPCR structures were solved as inactive forms, and an agonist bound fully active structure is still hard to obtain. In a structural point of view, β2AR is relatively well studied since its fully active structure as a complex with G protein as well as several inactive structures are available. The structural comparison of inactive and active states gives an important clue in understanding the activation mechanism of β2AR. In this review, structural features of inactive and active states of β2AR, the interaction of β2AR with heterotrimeric G protein, and the comparison with β1AR will be discussed.

Citing Articles

Early Events in βAR Dimer Dynamics Mediated by Activation-Related Microswitches.

Kotipalli A, Koulgi S, Jani V, Sonavane U, Joshi R J Membr Biol. 2024; 257(5-6):323-344.

PMID: 39240374 DOI: 10.1007/s00232-024-00324-1.


Differential Behavior of Conformational Dynamics in Active and Inactive States of Cannabinoid Receptor 1.

Isu U, Polasa A, Moradi M J Phys Chem B. 2024; 128(35):8437-8447.

PMID: 39169808 PMC: 11382280. DOI: 10.1021/acs.jpcb.4c02828.


A Study on the Robustness and Stability of Explainable Deep Learning in an Imbalanced Setting: The Exploration of the Conformational Space of G Protein-Coupled Receptors.

Gutierrez-Mondragon M, Vellido A, Konig C Int J Mol Sci. 2024; 25(12).

PMID: 38928278 PMC: 11203844. DOI: 10.3390/ijms25126572.


Coevolution-Driven Method for Efficiently Simulating Conformational Changes in Proteins Reveals Molecular Details of Ligand Effects in the β2AR Receptor.

Mitrovic D, Chen Y, Marciniak A, Delemotte L J Phys Chem B. 2023; 127(46):9891-9904.

PMID: 37947090 PMC: 10683026. DOI: 10.1021/acs.jpcb.3c04897.


L-DOPA and Droxidopa: From Force Field Development to Molecular Docking into Human β-Adrenergic Receptor.

Catte A, Biswas A, Mancini G, Barone V Life (Basel). 2022; 12(9).

PMID: 36143429 PMC: 9501711. DOI: 10.3390/life12091393.


References
1.
Palczewski K, Kumasaka T, Hori T, Behnke C, Motoshima H, Fox B . Crystal structure of rhodopsin: A G protein-coupled receptor. Science. 2000; 289(5480):739-45. DOI: 10.1126/science.289.5480.739. View

2.
Ring A, Manglik A, Kruse A, Enos M, Weis W, Garcia K . Adrenaline-activated structure of β2-adrenoceptor stabilized by an engineered nanobody. Nature. 2013; 502(7472):575-579. PMC: 3822040. DOI: 10.1038/nature12572. View

3.
Rosenbaum D, Cherezov V, Hanson M, Rasmussen S, Thian F, Kobilka T . GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function. Science. 2007; 318(5854):1266-73. DOI: 10.1126/science.1150609. View

4.
Cherezov V, Rosenbaum D, Hanson M, Rasmussen S, Thian F, Kobilka T . High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science. 2007; 318(5854):1258-65. PMC: 2583103. DOI: 10.1126/science.1150577. View

5.
Hanson M, Cherezov V, Griffith M, Roth C, Jaakola V, Chien E . A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. Structure. 2008; 16(6):897-905. PMC: 2601552. DOI: 10.1016/j.str.2008.05.001. View